about
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. ...
Read More
15.65
0.42
(2.76%)
2.0M
XNAS Volume
XNAS 09 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Regenxbio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..